Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Ibarra

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Critical Care (London, England)|July 3, 2024
The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patientsSebastian Morales, Pedro D Wendel-Garcia, Miguel Ibarra-Estrada, et al.
Medicina Intensiva|March 3, 2026
Tracheostomy decannulation process model: an interprofessional, Latin-American Delphi consensusRoque Basoalto, Yorschua Jalil, Javiera Guzman, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|January 24, 2026
Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trialJing-Chao Luo, Li Ma, Ming-Hao Luo, et al.
Journal of Critical Care|August 28, 2023
Awake prone positioning in acute hypoxaemic respiratory failure: An international expert guidanceIvan Pavlov, Jie Li, Aileen Kharat, et al.
Critical Care (London, England)|March 14, 2023
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trialMiguel Ibarra-Estrada, Eduardo Kattan, Pavel Aguilera-González, et al.
Lancet (London, England)|January 28, 2023
The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trialDaren K Heyland, Jayshil Patel, Charlene Compher, et al.
Critical Care (London, England)|June 27, 2022
Lung ultrasound response to awake prone positioning predicts the need for intubation in patients with COVID-19 induced acute hypoxemic respiratory failure: an observational studyMiguel Ibarra-Estrada, María J Gamero-Rodríguez, Marina García-de-Acilu, et al.
BMC Nephrology|January 4, 2022
The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized TrialJonathan S Chávez-Iñiguez, Miguel Ibarra-Estrada, Sergio Sánchez-Villaseca, et al.
Critical Care (London, England)|March 29, 2022
Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trialMiguel Ibarra-Estrada, Jie Li, Ivan Pavlov, et al.
The Lancet. Respiratory Medicine|August 23, 2021
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trialStephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Critical Care (London, England)|July 3, 2024
The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patientsSebastian Morales, Pedro D Wendel-Garcia, Miguel Ibarra-Estrada, et al.
Medicina Intensiva|March 3, 2026
Tracheostomy decannulation process model: an interprofessional, Latin-American Delphi consensusRoque Basoalto, Yorschua Jalil, Javiera Guzman, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|January 24, 2026
Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trialJing-Chao Luo, Li Ma, Ming-Hao Luo, et al.
Journal of Critical Care|August 28, 2023
Awake prone positioning in acute hypoxaemic respiratory failure: An international expert guidanceIvan Pavlov, Jie Li, Aileen Kharat, et al.
Critical Care (London, England)|March 14, 2023
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trialMiguel Ibarra-Estrada, Eduardo Kattan, Pavel Aguilera-González, et al.
Lancet (London, England)|January 28, 2023
The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trialDaren K Heyland, Jayshil Patel, Charlene Compher, et al.
Critical Care (London, England)|June 27, 2022
Lung ultrasound response to awake prone positioning predicts the need for intubation in patients with COVID-19 induced acute hypoxemic respiratory failure: an observational studyMiguel Ibarra-Estrada, María J Gamero-Rodríguez, Marina García-de-Acilu, et al.
BMC Nephrology|January 4, 2022
The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized TrialJonathan S Chávez-Iñiguez, Miguel Ibarra-Estrada, Sergio Sánchez-Villaseca, et al.
Critical Care (London, England)|March 29, 2022
Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trialMiguel Ibarra-Estrada, Jie Li, Ivan Pavlov, et al.
The Lancet. Respiratory Medicine|August 23, 2021
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trialStephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, et al.
Pageof 3